HOB Biotech Group Corp.,Ltd
SSE:688656.SS
126.5 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 77.613 | 95.306 | 101.793 | 115.976 | 85.6 | 94.252 | 109.62 | 109.759 | 80.775 | 65.791 | 103.324 | 75.19 | 76.087 | 81.831 | 88.335 | 86.552 | 60.99 | 77.945 | 65.059 | 58.486 | 20.366 | 62.362 | 70.866 | 73.438 | 52.461 |
| Cost of Revenue
| 32.613 | 35.697 | 35.579 | 44.846 | 32.457 | 37.671 | 36.894 | 40.411 | 34.436 | 27.798 | 35.249 | 26.908 | 28.181 | 28.707 | 25.029 | 24.175 | 20.635 | 27.19 | 19.271 | 29.94 | 7.777 | 19.96 | 23.896 | 0 | 0 |
| Gross Profit
| 45 | 59.609 | 66.214 | 71.129 | 53.143 | 56.581 | 72.726 | 69.348 | 46.338 | 37.993 | 68.075 | 48.282 | 47.906 | 53.124 | 63.305 | 62.377 | 40.355 | 50.756 | 45.788 | 28.546 | 12.589 | 42.402 | 46.97 | 73.438 | 52.461 |
| Gross Profit Ratio
| 0.58 | 0.625 | 0.65 | 0.613 | 0.621 | 0.6 | 0.663 | 0.632 | 0.574 | 0.577 | 0.659 | 0.642 | 0.63 | 0.649 | 0.717 | 0.721 | 0.662 | 0.651 | 0.704 | 0.488 | 0.618 | 0.68 | 0.663 | 1 | 1 |
| Reseach & Development Expenses
| 9.282 | 11.183 | 11.342 | 10.789 | 10.616 | 11.622 | 12.793 | 12.224 | 10.37 | 13.124 | 10.157 | 8.247 | 7.213 | 10.954 | 7.991 | 6.332 | 6.508 | 6.851 | 5.835 | 5.991 | 5.453 | 5.854 | 6.498 | 0 | 0 |
| General & Administrative Expenses
| 13.819 | -26.479 | 40.969 | -2.8 | 15.529 | -23.413 | 29.365 | -4.399 | 9.921 | -21.52 | 24.546 | -0.516 | 7.377 | -10.251 | 14.7 | -2.216 | 7.035 | 0.603 | -3.538 | 2.67 | 3.738 | 6.824 | -4.774 | 0 | 0 |
| Selling & Marketing Expenses
| 19.384 | -41.861 | 58.872 | 25.89 | 22.998 | 21.084 | 26.906 | 25.298 | 20.811 | 20.157 | 22.151 | 19.532 | 16.817 | 21.355 | 16.498 | 16.343 | 13.854 | 15.685 | 12.62 | 11.078 | 10.202 | 15.349 | 14.008 | 0 | 0 |
| SG&A
| 33.204 | -68.339 | 101.545 | 40.183 | 38.527 | -2.329 | 56.271 | 20.899 | 30.732 | -1.364 | 46.697 | 19.016 | 24.194 | 11.105 | 31.198 | 14.127 | 20.889 | 16.288 | 9.083 | 15.618 | 13.461 | 22.174 | 9.234 | 0 | 0 |
| Other Expenses
| 0.741 | 104.371 | -51.111 | -0.349 | 0.103 | -0.327 | 0.382 | 0.859 | -0.429 | 30.372 | -11.053 | 12.138 | 0.767 | 1.848 | -0.174 | -0.133 | 0.064 | -0.117 | 1.539 | 0.643 | -26.955 | 0.364 | 2.754 | -47.308 | -39.659 |
| Operating Expenses
| 43.226 | 48.349 | 61.776 | 50.972 | 49.177 | 44.709 | 53.151 | 51.27 | 40.672 | 42.133 | 45.801 | 39.401 | 32.174 | 44.929 | 31.596 | 28.12 | 28.107 | 29.903 | 23.048 | 0.643 | -26.955 | 32.432 | 25.058 | -47.308 | -39.659 |
| Operating Income
| 1.774 | 11.26 | 7.395 | 20.158 | 3.715 | 12.483 | 19.426 | 18.138 | 5.796 | -2.973 | 23.352 | 10.817 | 16.371 | 11.127 | 34.495 | 37.366 | 14.535 | 20.327 | 22.171 | 29.19 | -6.588 | 9.996 | 21.125 | 26.13 | 12.803 |
| Operating Income Ratio
| 0.023 | 0.118 | 0.073 | 0.174 | 0.043 | 0.132 | 0.177 | 0.165 | 0.072 | -0.045 | 0.226 | 0.144 | 0.215 | 0.136 | 0.391 | 0.432 | 0.238 | 0.261 | 0.341 | 0.499 | -0.323 | 0.16 | 0.298 | 0.356 | 0.244 |
| Total Other Income Expenses Net
| 0.217 | -0.376 | -0.256 | -0.349 | 0.103 | -0.327 | 0.382 | 0.859 | -0.131 | -1.217 | 1.622 | 2.013 | 0.11 | 1.848 | -0.174 | 3.217 | 2.351 | 0.927 | 0.409 | -0.328 | -0.311 | 0.364 | 2.591 | 0.461 | 0.089 |
| Income Before Tax
| 1.991 | 10.884 | 7.139 | 19.193 | 3.817 | 12.156 | 19.808 | 18.997 | 5.665 | -4.189 | 23.335 | 10.852 | 16.481 | 12.975 | 34.32 | 37.233 | 14.599 | 20.211 | 22.931 | 28.862 | -6.9 | 10.36 | 23.715 | 26.592 | 12.892 |
| Income Before Tax Ratio
| 0.026 | 0.114 | 0.07 | 0.165 | 0.045 | 0.129 | 0.181 | 0.173 | 0.07 | -0.064 | 0.226 | 0.144 | 0.217 | 0.159 | 0.389 | 0.43 | 0.239 | 0.259 | 0.352 | 0.493 | -0.339 | 0.166 | 0.335 | 0.362 | 0.246 |
| Income Tax Expense
| 0.352 | 0.643 | 0.557 | 3.021 | 0.008 | 3.458 | 2.745 | 2.988 | 0.103 | -1.368 | 3.224 | 0.054 | 2.918 | 1.539 | 4.645 | 5.488 | 1.263 | 2.285 | 3.316 | 45.496 | -28.521 | 1.423 | 3.322 | -43.96 | -38.031 |
| Net Income
| 1.639 | 10.241 | 6.582 | 16.171 | 3.81 | 8.698 | 17.063 | 16.01 | 5.562 | -2.821 | 20.112 | 10.798 | 13.562 | 11.436 | 29.675 | 31.745 | 13.337 | 17.926 | 19.616 | 24.409 | -5.333 | 8.937 | 20.393 | 23.244 | 11.264 |
| Net Income Ratio
| 0.021 | 0.107 | 0.065 | 0.139 | 0.045 | 0.092 | 0.156 | 0.146 | 0.069 | -0.043 | 0.195 | 0.144 | 0.178 | 0.14 | 0.336 | 0.367 | 0.219 | 0.23 | 0.302 | 0.417 | -0.262 | 0.143 | 0.288 | 0.317 | 0.215 |
| EPS
| 0.03 | 0.16 | 0.11 | 0.26 | 0.06 | 0.14 | 0.27 | 0.25 | 0.088 | -0.045 | 0.19 | 0.1 | 0.22 | 0.11 | 0.51 | 0.55 | 0.23 | 0.31 | 0.41 | 0.42 | -0.11 | 0.15 | 0.43 | 0.4 | 0.24 |
| EPS Diluted
| 0.03 | 0.16 | 0.11 | 0.26 | 0.06 | 0.14 | 0.26 | 0.25 | 0.088 | -0.045 | 0.19 | 0.1 | 0.22 | 0.11 | 0.51 | 0.55 | 0.23 | 0.31 | 0.41 | 0.42 | -0.11 | 0.15 | 0.43 | 0.4 | 0.24 |
| EBITDA
| 2.774 | 26.685 | 7.01 | 32.803 | 12.342 | 25.722 | 32.031 | 31.224 | 17.564 | 7.363 | 33.567 | 19.855 | 25.425 | 20.903 | 41.905 | 43.056 | 20.537 | 24.699 | 25.687 | 18.255 | -2.832 | 14.171 | 25.72 | 73.438 | 52.461 |
| EBITDA Ratio
| 0.036 | 0.28 | 0.069 | 0.283 | 0.144 | 0.273 | 0.292 | 0.284 | 0.217 | 0.112 | 0.325 | 0.264 | 0.334 | 0.255 | 0.474 | 0.497 | 0.337 | 0.317 | 0.395 | 0.312 | -0.139 | 0.227 | 0.363 | 1 | 1 |